StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
300029.SZ$2.77+0.00%
Fair $2.77+0.0%

300029.SZ

Jiangsu Huasheng Tianlong Photoelectric Co.,Ltd.

Technology / SemiconductorsShenzhen

$2.77

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $2.77Fund rank 24/100 · Data gapFallback financials|
SA 22/D
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $4.4M · quality 43.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 6/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

22/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 300029.SZLocal privado en este navegador · Jiangsu Huasheng Tianlong Photoelectric Co.,Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$555M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

76.6%

↑

Gross Margin

12.0%

↓

Debt/Equity

-0.02

↓
52-Week Range$3
$3$7

TradingView lightweight chart

300029.SZ price, volumen y niveles de valoración

Último $2.770Periodo -89.7%
Fair value: $2.770

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+8.6%

FCF CAGR

—

FCF margin

1.4%

FCF / Net income

-0.23x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $320.0M · net income $-18.9M · FCF $4.4M

2022-FY → 2025-FY

Gross margin

12.0%+0.3% pts

Operating margin

4.4%+9.1% pts

Net margin

-5.9%-11.0% pts

FCF margin

1.4%+32.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$320.0M$320.0M$161.1M$368.4M$249.6M
Net Income$-18.9M$-18.9M$-27.3M$-8.6M$12.6M
EBITDA$-18.7M$-18.7M$-27.9M$-10.5M$16.4M
EPS-0.09-0.09-0.14-0.040.06
Gross Margin12.0%12.0%14.4%7.9%11.7%
Operating Margin4.4%4.4%-5.7%1.6%-4.8%
Net Margin-5.9%-5.9%-16.9%-2.3%5.1%
Balance Sheet
Debt/Equity-0.02-0.02———
Current Ratio0.930.93———
Cash Flow
Free Cash Flow$4.4M$4.4M$-12.1M$17.4M$-76.6M
Returns
ROE76.6%76.6%923.6%-40.0%42.2%
Valuation
P/E————133.33
EV/EBITDA————101.47
P/B———65.4056.20
Growth & Yield
Revenue Growth98.6%98.6%-56.3%47.6%—
EPS Growth30.8%30.8%-218.2%-167.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -46.6%

Total return

-46.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.14 → -0.09

Residual

-46.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-46.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.